Renovia ^Companies

Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022 after its investors conducted a strategic review including considering a sale of the company. In January 2023, substantially all the assets of the company, including its intellectual property, were sold to Axena Health, Inc.